Debate: PRO position. Should microalbuminuria ever be considered as a renal endpoint in any clinical trial?
- PMID: 20413960
- DOI: 10.1159/000292501
Debate: PRO position. Should microalbuminuria ever be considered as a renal endpoint in any clinical trial?
Comment in
-
Editorial perspective. Should microalbuminuria ever be considered as a renal endpoint in any clinical trial?Am J Nephrol. 2010;31(5):469-70. doi: 10.1159/000292500. Epub 2010 Apr 22. Am J Nephrol. 2010. PMID: 20413964 No abstract available.
Similar articles
-
Debate: CON position. Should microalbuminuria ever be considered as a renal endpoint in any clinical trial?Am J Nephrol. 2010;31(5):462-5; discussion 466-7. doi: 10.1159/000313553. Epub 2010 Apr 22. Am J Nephrol. 2010. PMID: 20413961 No abstract available.
-
Editorial perspective. Should microalbuminuria ever be considered as a renal endpoint in any clinical trial?Am J Nephrol. 2010;31(5):469-70. doi: 10.1159/000292500. Epub 2010 Apr 22. Am J Nephrol. 2010. PMID: 20413964 No abstract available.
-
[Microalbuminuria in arterial hypertension].An Med Interna. 1998 Jul;15(7):381-3. An Med Interna. 1998. PMID: 9710992 Review. Spanish.
-
Slowing progression along the renal disease continuum.J Am Osteopath Assoc. 2005 Apr;105(4):207-15. J Am Osteopath Assoc. 2005. PMID: 15928338 Review.
-
Evidence for the use of urinary albumin as marker of kidney involvement in unselected populations.Scand J Clin Lab Invest Suppl. 2008;241:52-6. doi: 10.1080/00365510802145026. Scand J Clin Lab Invest Suppl. 2008. PMID: 18569965
Cited by
-
Soluble tumor necrosis factor receptor type 1 predicts cardiorenal outcomes and better associated with distinct cardiovascular or renal outcomes than precedential renal or cardiovascular events in type 2 diabetes mellitus.Ther Adv Endocrinol Metab. 2023 Oct 29;14:20420188231207345. doi: 10.1177/20420188231207345. eCollection 2023. Ther Adv Endocrinol Metab. 2023. PMID: 37916029 Free PMC article.
-
Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy.Nephrol Dial Transplant. 2014 Aug;29(8):1563-70. doi: 10.1093/ndt/gfu039. Epub 2014 Mar 2. Nephrol Dial Transplant. 2014. PMID: 24589724 Free PMC article. Clinical Trial.
-
A perspective on chronic kidney disease progression.Am J Physiol Renal Physiol. 2017 Mar 1;312(3):F375-F384. doi: 10.1152/ajprenal.00266.2016. Epub 2016 Dec 14. Am J Physiol Renal Physiol. 2017. PMID: 27974318 Free PMC article. Review.
-
Urinary exosomes as a novel biomarker for evaluation of α-lipoic acid's protective effect in early diabetic nephropathy.J Clin Lab Anal. 2017 Nov;31(6):e22129. doi: 10.1002/jcla.22129. Epub 2017 Jan 23. J Clin Lab Anal. 2017. PMID: 28116765 Free PMC article. Clinical Trial.
-
Correlation of Microalbuminuria with Estimated GFR (eGFR) by Cockcroft-Gault and MDRD Formula in Type 2 Diabetics and Hypertensives.Indian J Clin Biochem. 2015 Jul;30(3):271-4. doi: 10.1007/s12291-014-0439-z. Epub 2014 May 11. Indian J Clin Biochem. 2015. PMID: 26089611 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical